Parkinson's patch gets FDA approval; NC plays host to nanotech summit;

> Neupro, a dopamine agonist patch for Parkinson's and restless-leg syndrome, got FDA approval, and its producer, Belgium's UCB, plans for a July launch in the U.S. Release

> North Carolina is playing host to the Nanotech Commercialization Conference this week, and with 40 nanobiotechnology companies in the state alone, the field could be a huge boon to the local economy. Story

> Frost Gamma Investments Trust bought about 24 million shares of Alliqua ($ALQA), a New York-based company developing a transdermal drug delivery platform using a proprietary hydrogel. Release

> Nordson ASYMTEK has joined forces with the University of Greenwich to develop state-of-the-art drug delivery systems using the company's DispenseMate D-583 benchtop dispensing technology. Report

And Finally... Inovio Pharmaceuticals ($INO) scored a $750,000 grant from the Department of Defense to test the safety of its surface electroporation drug delivery system, with the aim of developing synthetic vaccines to combat bioterrorism. News

Suggested Articles

Chiasma's new acromegaly pill Mycapssa, aiming to convert patients from injectables, turned out positive 48-week data from an extension study.

Medicated chewing gum is a prime drug delivery target, but it's tough to test. An experimental set of robot jaws could ease that burden.

J&J has new data that should convince regulators to clear its subcutaneous Darzalex in another indication—widening its edge over a Sanofi rival.